Marija Ostojić

About Marija Ostojić

Marija Ostojić, With an exceptional h-index of 4 and a recent h-index of 4 (since 2020), a distinguished researcher at Univerzitet u Beogradu, specializes in the field of Cancer biology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Exploring novel genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer

Nischarin expression may have differing roles in male and female melanoma patients

Nischarin is a potential druggable target in both epithelial and stromal compartments of pancreatic ductal adenocarcinoma

Exploring novel inflammation-related genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer

Preclinical validation of rilmenidine for repurposing in pancreatic ductal adenocarcinoma

Enriching Chemical Space of Bioactive Scaffolds by New Ring Systems: Benzazocines and Their Metal Complexes as Potential Anticancer Drugs

Pan-cancer analysis reveals that nischarin may not be the universal tumor suppressor

Association of adiponectin receptors with metabolic and immune homeostasis parameters in colorectal cancer: In silico analysis and observational findings

Marija Ostojić Information

University

Position

PhD student Faculty of Biology

Citations(all)

36

Citations(since 2020)

35

Cited By

9

hIndex(all)

4

hIndex(since 2020)

4

i10Index(all)

1

i10Index(since 2020)

1

Email

University Profile Page

Google Scholar

Marija Ostojić Skills & Research Interests

Cancer biology

Top articles of Marija Ostojić

Exploring novel genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer

Frontiers in Genetics

2023/8/31

Nischarin expression may have differing roles in male and female melanoma patients

Journal of Molecular Medicine

2023/8

Marija Ostojić
Marija Ostojić

H-Index: 1

Nischarin is a potential druggable target in both epithelial and stromal compartments of pancreatic ductal adenocarcinoma

Cancer Research

2023/4/4

Marija Ostojić
Marija Ostojić

H-Index: 1

Exploring novel inflammation-related genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer

medRxiv

2023

Preclinical validation of rilmenidine for repurposing in pancreatic ductal adenocarcinoma

Molecular oncology

2023

Enriching Chemical Space of Bioactive Scaffolds by New Ring Systems: Benzazocines and Their Metal Complexes as Potential Anticancer Drugs

Inorganic Chemistry

2022/12/6

Pan-cancer analysis reveals that nischarin may not be the universal tumor suppressor

2022/11/22

Marija Ostojić
Marija Ostojić

H-Index: 1

Association of adiponectin receptors with metabolic and immune homeostasis parameters in colorectal cancer: In silico analysis and observational findings

International Journal of Environmental Research and Public Health

2022/11/14

Marija Ostojić
Marija Ostojić

H-Index: 1

Metabolic and inflammatory homeostasis disorders in the pathogenesis of colorectal cancer

Archives of Pharmacy

2022/10/17

Marija Ostojić
Marija Ostojić

H-Index: 1

Nischarin agonist rilmenidine inhibits pancreatic ductal adenocarcinoma cell migration and invasion

Cancer Research

2022/6/15

Rilmenidine binds to and inhibits the activity of MDR pumps in pancreatic ductal adenocarcinoma

STRATAGEM CA17104, New Diagnostic and Therapeutic Tools against Multidrug Resistant Tumors, 5th Annual Meeting, 29th June-1st July 2022, Coimbra, Portugal

2022

Marija Ostojić
Marija Ostojić

H-Index: 1

Abstract PO-040: Nischarin is expressed in pancreatic ductal adenocarcinoma and is a potential target for drug repurposing

Cancer Research

2021/11/15

A Fluorescence-Based Assay for Measuring Glucose Uptake in Living Melanoma Cells

Melanoma: Methods and Protocols

2021

Marija Ostojić
Marija Ostojić

H-Index: 1

See List of Professors in Marija Ostojić University(Univerzitet u Beogradu)